Lmr Partners LLP Biogen Inc. Call Options Transaction History

Lmr Partners LLP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $17.1 Million - $19.3 Million	67,500 Added 270.0%	92,500 $23.8 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $6.88 Million - $7.95 Million	25,000 New	25,000 $7.12 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $133 Million - $184 Million	685,300 New	685,300 $183 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.